Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:849168.
doi: 10.1155/2013/849168. Epub 2013 Nov 3.

Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia

Affiliations

Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia

Thomas Godet et al. Case Rep Hematol. 2013.

Abstract

Low molecular weight heparins (LMWH) are commonly used in the ICU setting for thromboprophylaxis as well as curative decoagulation as required during renal replacement therapy (RRT). A rare adverse event revealing immunoallergic LMWH induced thrombopenia (HIT) is skin necrosis at injection sites. We report the case of a patient presenting with skin necrosis witnessing an HIT after RRT, without thrombocytopenia. The mechanism remains unclear. Anti-PF4/heparin antibodies, functional tests (HIPA and/or SRA), and skin biopsy are of great help to evaluate differential diagnosis with a low pretest probability 4T's score.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Skin necrosis lesion at injection sites of left thigh.
Figure 2
Figure 2
Timeline of platelets count and anticoagulant therapies. Skin necrosis appeared on day 15. Platelet count increased after danaparoid initiation. UFH: unfractionated heparin; LMWH: low molecular weight heparin; RRT: renal replacement therapy.
Figure 3
Figure 3
Skin biopsy showing leukocytoclastic vasculitis and intravascular microthrombi.

References

    1. Warkentin TE, Linkins L-A. Non-necrotizing heparin-induced skin lesions and the 4T’s score. Journal of Thrombosis and Haemostasis. 2010;8(7):1483–1485. - PubMed
    1. Schindewolf M, Kroll H, Ackermann H, et al. Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 2010;8(7):1486–1491. - PubMed
    1. Wütschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Safety. 1999;20(6):515–525. - PubMed
    1. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Journal of Thrombosis and Haemostasis. 2006;4(4):759–765. - PubMed
    1. Harenberg J, Huhle G, Wang L, Hoffmann U, Bayerl C, Kerowgan M. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG. Allergy. 1999;54(5):473–477. - PubMed

LinkOut - more resources